Cannabidiol Effects on Cardiovascular System and Exercise Responses

NCT05232123 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2024-03-27

No results posted yet for this study

Summary

To identify the autonomic effects of recreationally-relevant doses of cannabidiol (CBD) in an older population, and to evaluate the effect of CBD on exercise performance and recovery.

Conditions

  • Healthy

Interventions

DRUG

Placebo

Placebo oral product formulated in MCT (medium chain triglyceride) oil

DRUG

Cannabidiol

Cannabidiol oral product formulated in MCT (medium chain triglyceride) oil

Sponsors & Collaborators

  • Castleton University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05232123 on ClinicalTrials.gov